Keywords: cambridge, stops, cerestat, trial, brain, injury, there

Cambridge Stops Cerestat Trial In Brain Injury

Article | 25 September 1997

Print This

There was further disappointment for Cambridge Neuroscience with thenews that it had stopped its Phase III trial of Cerestat (aptiganel) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in